Market revenue in 2022 | USD 2,204.9 million |
Market revenue in 2030 | USD 1,937.9 million |
Growth rate | -1.6% (CAGR from 2022 to 2030) |
Largest segment | Hiv |
Fastest growing segment | Herpes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | HIV, Hepatitis, Herpes, Influenza |
Key market players worldwide | Roche Holding AG, GSK PLC ADR, AbbVie Inc, Merck & Co Inc, Johnson & Johnson, Bristol-Myers Squibb Co, Dr Reddy's Laboratories Ltd ADR, Aurobindo Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antiviral drugs market will help companies and investors design strategic landscapes.
Hiv was the largest segment with a revenue share of 34.36% in 2022. Horizon Databook has segmented the France antiviral drugs market based on hiv, hepatitis, herpes, influenza covering the revenue growth of each sub-segment from 2018 to 2030.
France is expected to witness significant growth over the forecast period owing to various initiatives undertaken by public and private organizations focusing on developing & commercializing novel therapeutic products.
Moreover, increasing investments in the development of novel advanced therapy products in the country are anticipated to support market growth over the forecast period. Such proactive government initiatives increase accessibility to treatment options such as antiviral drugs, thereby playing a key role in reducing the national disease burden.
In October 2020, France launched a flu vaccine campaign to spread awareness regarding flu and influenza in the country. Such awareness programs help people identify symptoms, thereby creating more demand for influenza vaccines and drugs. France has a blend of several regional and multinational players offering antiviral therapeutics.
Horizon Databook provides a detailed overview of country-level data and insights on the France antiviral drugs market , including forecasts for subscribers. This country databook contains high-level insights into France antiviral drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account